ARVN | Arvinas, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	26.72 - 27.72
52 Week Range	13.57 - 53.08
Beta	1.65
Implied Volatility	73.04%
IV Rank	14.57%
Day's Volume	308,213
Average Volume	596,048
Shares Outstanding	68,648,100
Market Cap	1,856,244,624
Sector	Healthcare
Industry	Biotechnology
IPO Date	2018-09-27

Valuation
Profitability
Growth
Health
P/E Ratio	-5.10
Forward P/E Ratio	N/A
EPS	-5.30
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	445
Country	USA
Website	ARVN

Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer (mCRPC); ARV-471, a PROTAC protein degrader targeting the estrogen receptor protein for the treatment of patients with metastatic ER positive/HER2 negative breast cancer; and ARV-766 an investigational orally bioavailable PROTAC protein degrader for the treatment of men with mCRPC. The company has collaborations with Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., and Bayer AG. Arvinas, Inc. was founded in 2013 and is based in New Haven, Connecticut.

ARVN's peers: AADI, ADCT, AGIO, ALLK, CCCC, GLUE, NRIX, FHTX, RLAY, STOK, PLRX, BDTX, STTK, KYMR, RARE, CRNX, RVMD, KURA, IPSC, CGC, CYTK, ERAS, FOLD, PBYI, PRTG, PTGX, RAPT, RNA, RYTM, SAGE, SRRK, SWTX, TNGX, PROK

*Chart delayed

Analyzing fundamentals for ARVN we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is on medium level and Health is very weak. For more detailed analysis please see ARVN Fundamentals page.

Watching at ARVN technicals we can see that long-term trend is bearish, while middle-term trend is bullish, as well as bullish short-term trend. More technicals details can be found on ARVN Technicals page.